Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study

Hussam Al-Kateb, Andrew P Boright, Lucia Mirea, Xinlei Xie, Rinku Sutradhar, Alireza Mowjoodi, Bhupinder Bharaj, Michelle Liu, Jean M Bucksa, Valerie L Arends, Michael W Steffes, Patricia A Cleary, Wanjie Sun, John M Lachin, Paul S Thorner, Michael Ho, Amy Jayne McKnight, A Peter Maxwell, David A Savage, Kenneth K KiddJudith R Kidd, William C Speed, Trevor J Orchard, Rachel G Miller, Lei Sun, Shelley B Bull, Andrew D Paterson, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, Alexander Maxwell

Research output: Contribution to journalArticlepeer-review

69 Citations (Scopus)

Abstract

Despite familial clustering of nephropathy and retinopathy severity in type 1 diabetes, few gene variants have been consistently associated with these outcomes.
Original languageEnglish
Pages (from-to)218-228
Number of pages11
JournalDiabetes
Volume57
Issue number1
DOIs
Publication statusPublished - Jan 2008

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Fingerprint

Dive into the research topics of 'Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study'. Together they form a unique fingerprint.

Cite this